Completed PHASE1 INTERVENTIONAL NCT00003132

Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer

Phase I Study of Bryostatin-1 (NSC 339555) and Cisplatin in Advanced Malignancies

Sponsor: NYU Langone Health

Conditions Unspecified Adult Solid Tumor, Protocol Specific

Updated 7 times since 2017 Last updated: Nov 8, 2012 Started: Jan 31, 1998 Primary completion: Nov 30, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Unspecified Adult Solid Tumor, Protocol Specific and is currently completed. NYU Langone Health leads this study, which shows 7 recorded versions since 1998 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Jun 2019 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jan 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NYU Langone Health
National Cancer Institute (NCI)

Data source: NYU Langone Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States